KG-5 is an orally bioavailable PDGFRss and B-Raf allosteric inhibitor. References: Levine DM, Savarimuthu S, Squires A, Nicholson J, Jay M. Technology-assisted weight loss interventions in primary care: a systematic review. J Gen Intern Med. 2015 Jan;30(1):107-17. doi: 10.1007/s11606-014-2987-6. Epub 2014 Aug 19. Review. PubMed PMID: 25134692; PubMed Central PMCID: PMC4284284.

纯度：≥98%

CAS：877874-85-6